John Barr

Mr. John R. Barr has spent his career in medical devices. From October 2014 to August 2017, Mr. Barr served as CEO at Surgical Specialties Inc., a privately held medical device firm specializing in wound closure and surgical knives. Prior to that he served as Executive Vice President and President of Global Surgical at Bausch & Lomb Holdings Incorporated until the acquisition of Bausch and Lomb by Valeant Pharmaceuticals in August 2013. In that role, he was responsible for the global medical device business including sales and development of disposables, equipment and instruments used in various forms of eye surgery. Prior to Bausch and Lomb, Barr was the Chief Executive Officer of AGA Medical Holdings. AGA Medical was a pioneer and leader in the development, sale and manufacture of disposable devices used in minimally invasive repair of structural heart defects and other vascular defects. Mr. Barr led an IPO for the Company in 2009 and the business was sold to St. Jude Medical in 2010. He served as CEO of V.I. Technologies from and led an IPO of the company in 2008. The mission of V.I. Technologies was to commercialize pathogen inactivation technology for transfusion blood products. Prior to V.I. Technologies he served as President of North American Operations at Haemonetics Corp., where he had responsibility for Haemonetics' blood bank, commercial plasma and blood bank services businesses.